ALLMedicine™ Eosinophilic Esophagitis Center

May 13th, 2022 - There are approximately 15 million Americans, including 6 million children, who have a potentially life-threatening food allergy. The prevalence of this disease has increased over the last three decades, in both the United States and other develop...

May 12th, 2022 - This study is an open-label, uncontrolled study design to evaluate the longer-term safety profile as well as durability of response of administration of a single dose level of CC-93538. The study will enroll participants who participated in the CC...

May 8th, 2022 - Background: Eosinophilic esophagitis (EoE) is a Type-2 chronic inflammatory food antigen-driven disease of the esophagus, characterized by eosinophilic predominant inflammation and a constellation of symptoms. The incidence and prevalence of EoE h...

May 8th, 2022 - Eosinophilic esophagitis: from discovery to effective treatment.|2022|Bellanti JA,Settipane RA,|diagnosis,drug therapy,

May 1st, 2022 - A chromosomal duplication encompassing IL-33 causes a novel Hyper IgE phenotype characterized by eosinophilic esophagitis and generalized autoimmunity.|2022|Marwaha AK,Laxer R,Liang M,Muise AM,Eiwegger T,|

May 4th, 2020 - Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute ...

May 4th, 2020 - AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|standards,organization & administration,stand...

Apr 28th, 2020 - AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|therapeutic use,diagnosis,drug therapy,therap...

Apr 10th, 2020 - Treatment of Eosinophilic Esophagitis (EoE): Clinical Decision Support Tool.|2020| ,|

Apr 10th, 2020 - Spotlight: Treatment of Eosinophilic Esophagitis (EoE).|2020|Hirano I,Sharaf R,Stollman N,Wang K,Falck-Ytter Y,|standards,organization & administration,standards,methods,standards,diagnosis,immunology,therapy,methods,standards,complications,diagno...

May 13th, 2022 - There are approximately 15 million Americans, including 6 million children, who have a potentially life-threatening food allergy. The prevalence of this disease has increased over the last three decades, in both the United States and other develop...

May 12th, 2022 - This study is an open-label, uncontrolled study design to evaluate the longer-term safety profile as well as durability of response of administration of a single dose level of CC-93538. The study will enroll participants who participated in the CC...

Apr 13th, 2022 - This is a randomized, double-blind, placebo-controlled study of APT-1011, followed by an open-label extension (OLE) in adolescents (≥12 to <18 years) with EoE that will evaluate the efficacy and safety of APT-1011 3 mg administered HS for the indu...

Apr 6th, 2022 - The purpose of this research is to determine if antihistamines are safe and effective for the treatment of eosinophilic esophagitis. Antihistamines are frequently used for the treatment of gastroesophageal reflux disease and allergic disorders, an...

Apr 4th, 2022 - As the disease usually recurs once steroids are discontinued, and there is concern for complications of untreated disease, continuation of steroids is indefinite after induction of remission. The short-term safety of topical steroids has been well...

Apr 18th, 2022 - People with eosinophilic esophagitis (EoE) may run an increased risk of mood disorders, anxiety, and attention-deficit/hyperactivity disorder (ADHD) and should be screened for those conditions, researchers say. "It's important to know that there i...

Mar 15th, 2022 - A topical formulation of fluticasone designed to dissolve and coat the esophagus appears safe and effective for the treatment of eosinophilic esophagitis (EOE), according to new results from a phase 2b study. The results pave the way for phase 3 c...

Mar 14th, 2022 - A topical formulation of fluticasone designed to dissolve and coat the esophagus appears safe and effective for the treatment of eosinophilic esophagitis (EOE), according to new results from a phase 2b study. The results pave the way for phase 3 c.

Feb 1st, 2022 - Results from a double-blind, phase 3 trial suggest budesonide oral suspension may improve eosinophilic esophagitis (EoE) outcomes, providing promise for meeting the ongoing unmet treatment needs for individuals with the disease. In December 2020,.

Dec 20th, 2021 - The FDA approved the only biologic for severe asthma without any phenotype or biomarker limitations, manufacturers AstraZeneca and Amgen announced Friday. The first-in-class biologic tezepelumab-ekko (Tezspire) is indicated as an add-on maintenanc...